Balkrishan Simba Gill
2019
In 2019, Balkrishan Simba Gill earned a total compensation of $2.8M as Chief Executive Officer at Evelo Biosciences, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $216,000 |
|---|---|
| Option Awards | $2,046,000 |
| Salary | $540,000 |
| Total | $2,802,000 |
Gill received $2M in option awards, accounting for 73% of the total pay in 2019.
Gill also received $216K in non-equity incentive plan and $540K in salary.
Rankings
In 2019, Balkrishan Simba Gill's compensation ranked 4,363rd out of 13,971 executives tracked by ExecPay. In other words, Gill earned more than 68.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,363 out of 13,971 | 69th |
Division Manufacturing | 1,610 out of 5,695 | 72nd |
Major group Chemicals And Allied Products | 564 out of 2,194 | 74th |
Industry group Drugs | 475 out of 1,880 | 75th |
Industry Pharmaceutical Preparations | 359 out of 1,392 | 74th |
Source: SEC filing on April 27, 2020.
Gill's colleagues
We found two more compensation records of executives who worked with Balkrishan Simba Gill at Evelo Biosciences in 2019.
News
Evelo Biosciences Chief Development Officer Jonathan Zung receives $4.6M in 2021
April 26, 2022
Evelo Biosciences CEO Balkrishan Gill's 2020 pay falls 23% to $2.2M
April 26, 2021
Evelo Biosciences CEO Balkrishan Gill's 2019 pay falls 37% to $2.8M
April 27, 2020
Evelo Biosciences CEO Balkrishan Gill's 2018 pay jumps 144% to $4.5M
April 25, 2019